Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDF
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS RADAR August 2007NPS RADAR August 2007
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR August 2007 Professional publication - NPS RADAR - Complete issue | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Risedronate sodium (Actonel) and risedronate sodium with calcium carbonate (Actonel Combi) listing for osteoporosis in patients at high risk of fracture Professional publication - NPS RADAR - Brief item | The PBS restriction for risedronate was extended o allow the treatment of osteoporosis among patients aged 70 years or older with low bone mineral density scores but without an existing minimal trauma fracture. |
| Levonorgestrel-releasing intrauterine device (Mirena) now PBS listed for idiopathic menorrhagia Professional publication - NPS RADAR - Brief item | The restricted PBS listing for levonorgestrel-releasing intrauterine device (Mirena) was extended to include women in whom oral therapies for idiopathic menorrhagia are ineffective or contraindicated. |
| Be aware of dose ranges for new ramipril with felodipine combination (Triasyn) (see erratum below) Professional publication - NPS RADAR - Brief item | A new fixed-dose combination preparation of ramipril with felodipine (Triasyn) was PBS listed with a restricted dose range and dose titration cautions. |
| Perindopril arginine with indapamide hemihydrate (Coversyl Plus) Professional publication - NPS RADAR - Brief item | Perindopril arginine with indapamide (Coversyl Plus) was PBS listed after a formulation change from perindopril erbumine to perindopril arginine. |
| Alternative hydroxocobalamin product PBS listed Professional publication - NPS RADAR - Brief item | Hydroxocobalamin (Goldshield Hydroxocobalamin) has been temporarily PBS listed to provide an alternative to the currently listed product (Neo-Cytamen) while it is in short supply. |
| Cholinesterase inhibitors: change in authority requirements for cognitive testing Professional publication - NPS RADAR - Brief item | A change in the authority requirements for the cholinesterase inhibitors (donepezil hydrochloride, galantamine hydrochloride and rivastigmine hydrogen tartrate) means that the same cognitive test used in the initial treatment authority application must be used in requests for continued treatment. |
| Benzhexol hydrochloride misuse Professional publication - NPS RADAR - Brief item | Prescribers are reminded that benzhexol hydrochloride, an anticholinergic used in the treatment of Parkinson's disease and drug-induced extrapyramidal disorders, is a potential drug of abuse and that overdoses can be fatal. |
| Rosiglitazone and cardiovascular risk - NPS fact sheet Professional publication - NPS RADAR - Brief item | NPS has released a fact sheet discussing a recent meta-analysis that has raised concerns about a potential increase in cardiovascular risk among patients treated with rosiglitazone. |
| Additional content: Olmesartan medoxomil monotherapy or in combination with hydrochlorothiazide for hypertension Professional publication - NPS RADAR - Web only item | Table of questions to ask about fixed-dose combination preparations of olmesartan and hydrochlorothiazide for hypertension. |
| Budesonide with eformoterol dry powder inhaler (Symbicort) maintenance and reliever regimen for asthma Professional publication - NPS RADAR - Review | Reviews extended PBS listing for budesonide/eformoterol combination inhaler as an on-demand alternative to regular combination or corticosteroid therapy for asthma. |
| Fluticasone propionate with salmeterol xinafoate (Seretide) for chronic obstructive pulmonary disease Professional publication - NPS RADAR - Review | The PBS listing of fluticasone with salmeterol has been extended to include patients with moderate to severe COPD with symptoms that are poorly controlled despite regular beta2 agonist treatment. |
| Olmesartan medoxomil (Olmetec) monotherapy or in combination with hydrochlorothiazide (Olmetec Plus) for hypertension Professional publication - NPS RADAR - Review | Reviews use of olmesartan monotherapy or in combination with hydrochlorothiazide for hypertension, including indications for use, drug interactions, and patient monitoring |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2007-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
